Your browser doesn't support javascript.
loading
Differences in the neural correlates of schizophrenia with positive and negative formal thought disorder in patients with schizophrenia in the ENIGMA dataset.
Sharkey, Rachel J; Bacon, Chelsea; Peterson, Zeru; Rootes-Murdy, Kelly; Salvador, Raymond; Pomarol-Clotet, Edith; Karuk, Andriana; Homan, Philipp; Ji, Ellen; Omlor, Wolfgang; Homan, Stephanie; Georgiadis, Foivos; Kaiser, Stefan; Kirschner, Matthias; Ehrlich, Stefan; Dannlowski, Udo; Grotegerd, Dominik; Goltermann, Janik; Meinert, Susanne; Kircher, Tilo; Stein, Frederike; Brosch, Katharina; Krug, Axel; Nenadic, Igor; Sim, Kang; Spalletta, Gianfranco; Banaj, Nerisa; Sponheim, Scott R; Demro, Caroline; Ramsay, Ian S; King, Margaret; Quidé, Yann; Green, Melissa Jane; Nguyen, Dana; Preda, Adrian; Calhoun, Vince; Turner, Jessica; van Erp, Theo; Nickl-Jockschat, Thomas.
Afiliación
  • Sharkey RJ; Iowa Neuroscience Institute, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
  • Bacon C; Department of Psychiatry, University of Iowa, Iowa City, IA, USA.
  • Peterson Z; Iowa Neuroscience Institute, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
  • Rootes-Murdy K; Department of Psychiatry, University of Iowa, Iowa City, IA, USA.
  • Salvador R; Iowa Neuroscience Institute, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
  • Pomarol-Clotet E; Department of Psychiatry, University of Iowa, Iowa City, IA, USA.
  • Karuk A; Department of Psychology,, Georgia State University, Atlanta, GA, USA.
  • Homan P; FIDMAG Germanes Hospitalàries Research Foundation, CIBERSAM ISCIII, Barcelona, Spain.
  • Ji E; FIDMAG Germanes Hospitalàries Research Foundation, CIBERSAM ISCIII, Barcelona, Spain.
  • Omlor W; FIDMAG Germanes Hospitalàries Research Foundation, CIBERSAM ISCIII, Barcelona, Spain.
  • Homan S; Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich (PUK), Zurich, 8008, Switzerland.
  • Georgiadis F; Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich (PUK), Zurich, 8008, Switzerland.
  • Kaiser S; Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich (PUK), Zurich, 8008, Switzerland.
  • Kirschner M; Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich (PUK), Zurich, 8008, Switzerland.
  • Ehrlich S; Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich (PUK), Zurich, 8008, Switzerland.
  • Dannlowski U; Department of Psychiatry, Geneva University Hospitals, Geneva, Switzerland.
  • Grotegerd D; Department of Psychiatry, Geneva University Hospitals, Geneva, Switzerland.
  • Goltermann J; Translational Developmental Neuroscience Section, Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, TU Dresden, Dresden, Germany.
  • Meinert S; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Kircher T; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Stein F; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Brosch K; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Krug A; Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany.
  • Nenadic I; Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany.
  • Sim K; Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany.
  • Spalletta G; Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany.
  • Banaj N; Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany.
  • Sponheim SR; West Region, Institute of Mental Health, Singapore, Singapore.
  • Demro C; Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy.
  • Ramsay IS; Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy.
  • King M; Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, MN, USA.
  • Quidé Y; Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, MN, USA.
  • Green MJ; Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, MN, USA.
  • Nguyen D; The MIND Research Network, Albuquerque, NM, USA.
  • Preda A; School of Psychiatry, University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia.
  • Calhoun V; School of Psychiatry, University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia.
  • Turner J; Department of Pediatric Neurology, University of California Irvine, Irvine, CA, USA.
  • van Erp T; Department of Pediatric Neurology, University of California Irvine, Irvine, CA, USA.
  • Nickl-Jockschat T; Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, USA.
Mol Psychiatry ; 29(10): 3086-3096, 2024 Oct.
Article en En | MEDLINE | ID: mdl-38671214
ABSTRACT
Formal thought disorder (FTD) is a clinical key factor in schizophrenia, but the neurobiological underpinnings remain unclear. In particular, the relationship between FTD symptom dimensions and patterns of regional brain volume loss in schizophrenia remains to be established in large cohorts. Even less is known about the cellular basis of FTD. Our study addresses these major obstacles by enrolling a large multi-site cohort acquired by the ENIGMA Schizophrenia Working Group (752 schizophrenia patients and 1256 controls), to unravel the neuroanatomy of FTD in schizophrenia and using virtual histology tools on implicated brain regions to investigate the cellular basis. Based on the findings of previous clinical and neuroimaging studies, we decided to separately explore positive, negative and total formal thought disorder. We used virtual histology tools to relate brain structural changes associated with FTD to cellular distributions in cortical regions. We identified distinct neural networks positive and negative FTD. Both networks encompassed fronto-occipito-amygdalar brain regions, but positive and negative FTD demonstrated a dissociation negative FTD showed a relative sparing of orbitofrontal cortical thickness, while positive FTD also affected lateral temporal cortices. Virtual histology identified distinct transcriptomic fingerprints associated for both symptom dimensions. Negative FTD was linked to neuronal and astrocyte fingerprints, while positive FTD also showed associations with microglial cell types. These results provide an important step towards linking FTD to brain structural changes and their cellular underpinnings, providing an avenue for a better mechanistic understanding of this syndrome.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Psicología del Esquizofrénico / Encéfalo Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Psicología del Esquizofrénico / Encéfalo Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido